drugset / Trial / NCT06863987
A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents
NaParallel-groupDouble-blindTreatment
Summary
This study was an randomized, double-Blind, placebo-controlled, multicenter Phase II/III study.
Timeline
- Start
- 2025-02-05
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valsartan | Small molecule | 40 mg | Oral |
| Subject | Valsartan | Small molecule | 80 mg | Oral |